Intelligent Thermo-Self-Limited Magnetothermia with Heat-Triggered TERT Silencing for Precision Synergetic Cancer...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Hyperthermal therapy and gene therapy (GT) show promise for cancer treatment but face challenges like overheating damage and limited precision.
• Current methods struggle with precise temperature control in hyperthermal therapy and targeted delivery in GT, compromising overall effectiveness.

Purpose of the Study:

• To develop a novel nanoplatform for synergistic mild-thermal therapy (MTT) and gene therapy (GT) in cancer treatment.
• To engineer a system with self-limiting magnetothermal performance and heat-induced precision gene editing.
• To enhance therapeutic outcomes by overcoming the limitations of individual therapies.

Main Methods:

• Fabrication of a nanoplatform (IONP@H1THs) integrating iron oxide nanoparticles with functional DNA.
• Utilizing hairpin DNA self-assembly upon binding to telomerase reverse transcriptase (TERT) mRNA to enhance magnetothermal properties.
• Implementing self-limited heating by DNA unwinding and heat-triggered gene editing via Hsp70 promoter activation for in situ small interfering RNA synthesis.

Main Results:

• The IONP@H1THs nanoplatform demonstrated self-limiting magnetothermal performance for safe MTT.
• Heat-induced precision gene editing was achieved, specifically targeting TERT mRNA for knockdown.
• Synergistic effects of MTT and GT were observed, enhancing cancer treatment efficacy.

Conclusions:

• The developed nanoplatform offers a promising strategy for integrated cancer therapy.
• Self-limited MTT combined with heat-triggered precise GT represents an effective approach for tumor treatment.
• This innovative system addresses key limitations of current hyperthermal and gene therapies.